Skip to main content

Eli Lilly’s next-generation obesity drug helped patients lose up to 34 pounds in clinical trial

New drug is among next-generation weight-loss medications generating debate over insurance coverage, costs
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.